Molbio Diagnostics standalone net profit declines 65.88% in the September 2026 quarter

Sales decline 57.04% to Rs 248.88 crore

Net profit of Molbio Diagnostics declined 65.88% to Rs 31.38 crore in the quarter ended September 2026 as against Rs 91.96 crore during the previous quarter ended September 2025. Sales declined 57.04% to Rs 248.88 crore in the quarter ended September 2026 as against Rs 579.31 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	248.88	579.31	-57
OPM %	23.56	23.17	-
PBDT	56.34	131.92	-57
PBT	42.35	123.17	-66
NP	31.38	91.96	-66

Powered by Capital Market - Live News